This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the clinical efficacy and safety of JAK1 and JAK2 inhibitors for treating MF generated by hematologic or non‐hematologic conditions.
Tópico:
Myeloproliferative Neoplasms: Diagnosis and Treatment
